Humana said its Board of Directors expanded the number of authorized directors from ten to eleven and elected Robert S. Field as a director, effective immediately following the adjournment of the Company's April 16, 2026 Annual Meeting of Stockholders.

1. 01

   Humana said its Board of Directors expanded the number of authorized directors from ten to eleven and elected Robert S. Field as a director, effective immediately following the adjournment of the Company's April 16, 2026 Annual Meeting of Stockholders.

2. 02

   The company said the Board of Directors determined Mr. Field qualifies as an independent director under the New York Stock Exchange's director independence standards. It added that compensation will be in accordance with the Company's director compensation program, and Mr. Field will be granted restricted stock units (RSUs) in connection with his election to the Board.

3. 03

   Humana said no determination has yet been made regarding the appointment of Mr. Field to any committees of the Board. The company also disclosed that there are no arrangements between Mr. Field and any other person pursuant to which Mr. Field was elected to serve as a director, nor are there any transactions to which the Company or any of its subsidiaries is a party and in which Mr. Field has a material interest.

4. 04

   The company said Mr. Field is the Principal and Managing Member of ηMed Capital Management LLC and previously served as a senior analyst at Luxor Capital, where he led healthcare services investments. It added that his appointment followed a comprehensive search process led by the Humana Board and informed by shareholder engagement, including input from John Petry, Managing Member of Sessa Capital.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.